Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews-Reference-Cited by-同舟云学术

Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews

Published:2023-05-08 Issue:6 Volume:40 Page:2915-2926
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Hoenig Christian,van der Laan Roald,Reimann Andreas,Hoffmann Marina,Tyler Stephan,Wiesmann Claudia,Obradovic Marko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-023-02519-9.pdf

Reference25 articles.

1. Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6(3):210–20. https://doi.org/10.3978/j.issn.2072-1439.2013.12.24.

2. Matsumoto Y, Kinjo T, Motooka D, et al. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles. Emerg Microbes Infect. 2019;8(1):1043–53. https://doi.org/10.1080/22221751.2019.1637702.

3. Larsson LO, Polverino E, Hoefsloot W, et al. Pulmonary disease by non-tuberculous mycobacteria—clinical management, unmet needs and future perspectives. Expert Rev Respir Med. 2017;11(12):977–89. https://doi.org/10.1080/17476348.2017.1386563.

4. Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1–22. https://doi.org/10.1136/thoraxjnl-2015-207360.

5. Ringshausen FC, Wagner D, de Roux A, et al. Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009–2014. Emerg Infect Dis. 2016;22(6):1102–5. https://doi.org/10.3201/eid2206.151642.